Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helicobacter

Showing results (1051-1060 of 2,116) with videos related to

Pageof 212
Sort By:
Helicobacter|February 25, 2025
Vonoprazan-Amoxicillin Dual Therapy Versus Drug Sensitivity-Based Individualized Therapy as a Rescue Regimen for Helicobacter pylori Infection: A Multicenter, Randomized Controlled TrialYu-Xiang Liu, Han-Ning Liu, Heng-Qi Liu, et al.
Helicobacter|May 25, 2024
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European studyKallirroi Kotilea, Claudio Romano, Erasmo Miele, et al.
Helicobacter|December 28, 2020
Dialogue between gastrointestinal tract and skin: New insights into the Helicobacter pylori and atopic dermatitisQian Xue, Xia Li, Yuchen Li, et al.
Helicobacter|September 12, 2020
Review: Epidemiology of Helicobacter pyloriLinda Mezmale, Luiz Gonzaga Coelho, Dmitry Bordin, et al.
Helicobacter|September 12, 2020
Review: Helicobacter pylori infection in childrenJi-Hyun Seo, Kristen Bortolin, Nicola L Jones
Helicobacter|March 10, 2020
Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS studyCatharina J Alberts, Rima Jeske, Catherine de Martel, et al.
Helicobacter|March 25, 2020
Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trialToshihiko Kakiuchi, Akihiko Mizoe, Kentaroh Yamamoto, et al.
Helicobacter|October 29, 2019
Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathwayYanlei Guo, Ting Zhang, Yanyan Shi, et al.
Helicobacter|October 17, 2020
Antimicrobial resistance of Helicobacter pylori in an eastern German regionDirk Hofreuter, Johannes Behrendt, Annett Franz, et al.
Helicobacter|October 11, 2020
A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trialZhiqiang Song, Liya Zhou, Yan Xue, et al.
Pageof 212

Showing results (1051-1060 of 2,116) with videos related to

Sort By:
Pageof 212
Helicobacter|February 25, 2025
Vonoprazan-Amoxicillin Dual Therapy Versus Drug Sensitivity-Based Individualized Therapy as a Rescue Regimen for Helicobacter pylori Infection: A Multicenter, Randomized Controlled TrialYu-Xiang Liu, Han-Ning Liu, Heng-Qi Liu, et al.
Helicobacter|May 25, 2024
Helicobacter pylori infection found during upper endoscopy performed for the diagnosis of celiac, inflammatory bowel diseases, and eosinophilic esophagitis: A multicenter pediatric European studyKallirroi Kotilea, Claudio Romano, Erasmo Miele, et al.
Helicobacter|December 28, 2020
Dialogue between gastrointestinal tract and skin: New insights into the Helicobacter pylori and atopic dermatitisQian Xue, Xia Li, Yuchen Li, et al.
Helicobacter|September 12, 2020
Review: Epidemiology of Helicobacter pyloriLinda Mezmale, Luiz Gonzaga Coelho, Dmitry Bordin, et al.
Helicobacter|September 12, 2020
Review: Helicobacter pylori infection in childrenJi-Hyun Seo, Kristen Bortolin, Nicola L Jones
Helicobacter|March 10, 2020
Helicobacter pylori seroprevalence in six different ethnic groups living in Amsterdam: The HELIUS studyCatharina J Alberts, Rima Jeske, Catherine de Martel, et al.
Helicobacter|March 25, 2020
Effect of probiotics during vonoprazan-containing triple therapy on gut microbiota in Helicobacter pylori infection: A randomized controlled trialToshihiko Kakiuchi, Akihiko Mizoe, Kentaroh Yamamoto, et al.
Helicobacter|October 29, 2019
Helicobacter pylori inhibits GKN1 expression via the CagA/p-ERK/AUF1 pathwayYanlei Guo, Ting Zhang, Yanyan Shi, et al.
Helicobacter|October 17, 2020
Antimicrobial resistance of Helicobacter pylori in an eastern German regionDirk Hofreuter, Johannes Behrendt, Annett Franz, et al.
Helicobacter|October 11, 2020
A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trialZhiqiang Song, Liya Zhou, Yan Xue, et al.
Pageof 212